ent with the binaural estimates for the same stimulus conditions. Although our measurements represent only a limited investigation of higher-fre- 
in which the absolute threshold at the frequency of the combination tone is higher than at the primary frequencies, direct interpretation of probe level as combination-tone level would overestimate the cochlear amplitude of the combination tone. When the absolute threshold at the frequency of the combination tone is lower than the primary frequencies, as can l?e the case with combination tones higher in frequency than the primary tones, the probe level may underestimate the relative cochlear amplitude of the combination tone. 14. S. S. Stevens Growth hormone, along with at least two other polypeptide hormones, chorionic somatomammotropin (placental lactogen) and prolactin, forms a set of proteins with amino acid sequence homology and to some extent overlapping biological activities (1, 2) . Since the genes of this set of proteins probably have a common ancestral origin (1), they constitute an excellent model to study the evolution, structure, and differential regulation of related genes. In addition, since human growth hormone is of considerable medical importance and its supply is limited, the synthesis of growth hormone in bacteria might provide the required alternate soUrce of this critical hormone.
We have previously isolated and analyzed bacterial clones containing copies of complementary DNA (cDNA) transcripts of messenger RNA's (mRNA's) for these hormones. The complete sequence of rat pregrowth hormone mRNA (3) has been reported; in addition, sequence data have been presented for firagments of about 550 bases complementary to part of the coding (amino acid residues 24 to 191) and 3' untranslated portions of human chorionic somatomammotropin (hCS) (3, 4) and human growth hormone (hGH) mRNA's (5) . A partial sequence of rat prolactin has been determined by Gubbins et al. (6) . These sequerkce data showed that, whereas the growth hormone genes of 0036-8075t79/081040602$050/0 Copyright 0 1979 AAAS Princeton, N.J., 1954), ch. 9; P. Dalos, The Auditory Periphery (Academic Press, New York, 1973), chap. 6.
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Disorders and Stroke to Central Institute for the Deaf. We thank several of our colleagues for criticizing a draft of this report. 13 March 1979 the rat and man had significant homology, they also had diverged substantially, such that they differed more than the genes for the functionally distinct human hormones hCS and hGH.
We now report the synthesis, cloning, and sequence analysis of cDNA containing the entire coding and most of the noncoding portions of hGH mRNA. We also describe the insertion of these sequences into an "expression plasmid" containing part of the Escherichia coli tryptophan (trp) operon whose construction has been realized by Hallewell and Emtage (7) . We describe the use of this plasmid to promote the inducible bacterial synthesis of high levels of a hybrid protein, 70 percent of which is composed of amino acids coded for by the hGH gene.
Human growth hormone mRNA isolation. Polyadenylated RNA was isolated (8) from human pituitary tumors removed by transphenoidal hypophysectoniy. To obtain an indication of the integrity and the relative abundance of growth hormone mRNA in each sample, the individual mRNA preparations were translated in the wheat germ cell-free system, and the products were analyzed by electrophoresis on sodium dodecyl sulfate-polyacrylamide gels (Fig. 1) . Among the translation prodticts of the five acromegalic tumor RNA's ( Fig. 1,  lanes 1 to 5) by 24,000 daltons. This protein is asmed to be human pregrowth hormone sice it is similar in size to rat pregrowth brmone' (Fig. 1, " rat") and is precipimted by antiserum to hGH (data not sown). This assumption is further justibd by comparison with the translation :roducts of polyadenylated RNA isolatad from bovine pituitary (Fig. 1, "cow") 41d from a human prolactin-producing linor (Fig. 1, lane 6) . Both .-Molecular cloning ofhGH cDNA. The vIyadenylated RNA from the tumors that appeared to have the greate §t16un-dance of hGH mRNA by the translational assay were pooled for synthesis of double-stranded cDNA (Fig. 2) . Portions of the double-stranded cDNA were analyzed by restriction endonuclease digestion before and after treatment with SI nuclease. A high proportion of the cDNA was about 1000 nucleotides long (Fig. 2, lanes a and b) , the length expected for hGH mRNA, assuming analogy with rat pregrowth hormone mRNA (3) . Endonuclease Hae III digestion of the DNA generated a 550-base pair (bp) fragment (Fig. 2 , lanes h and j) previously reported to occur in hGH and hCS cDNA's (4, 5) . The prominence of this band supports the idea that the cDNA is highly enriched in hGH gene sequences. This is further suggested by the finding of a fragment of about 400 bp generated by digestion with Hinf I and Sma I (Fig. 2, lane g ). The fragment of about 500 bp generated by Pvu II (Fig. 2 , lanes e and i) extends beyond the previously cloned 550 bp fragment, which contains only one Pvu II site. However, its presence is predictable from the sequence of rat growth hormone cDNA (3) , and by the conservation between species of the amino acid sequence irl this region (9) . The fragments of about 350 bp and 150 bp generated by combined digestion with Pvu II and Bgl II (Fig. 2 , lane f) would also be anticipated from the previously determined struct ture of the 550 bp hGH fragment and knowledge of the existence of the addi. tional Pvu II site. Therefore, this cDNA preparation appears to be highly enriched in full-length copies of hGI-I mRNA.
The uncleaved cDNA was cloned in the plasmid pBR322 and E. coli X1776 in a P3 physical containment facility (10) by methods similar to those previously described (3). Briefly, the cDNA was first treated with SI nuclease and subsequently with DNA polymerase I in the presence of the four deoxynucleosida triphosphates to generate blunt-ended cDNA molecules. Synthetic DNA cosw taining the site for the restriction endd- I.1 (left). Translation products of mRNA isolated from growth hormone and prolactin-producing tumors and from bovine pituitary. These tisr s were stored in liquid nitrogen shortly after their removal until preparation of the RNA. A portion of polyadenylated RNA isolated from each, man tumor, the bovine pituitary, and the cultured rat pituitary tumor (GC) cells was used as a messenger in the wheat germ cell-free proteinW *nthesis system (20) . The 35S-labeled proteins were analyzed by electrophoresis and autoradiography on sodium dodecyl sulfate-polyacrylamideils (12.5 percent) (20) . The translation products from five acromegalic and one prolactin-secreting tumor are shown in lanes 1 to 5 and lane 6, spectively. The lanes labeled "cow" and "rat" show the translation products from bovine pituitary and rat GC cell RNA. Lane 7 shows the ;scteriophage T4 proteins (21) used as molecular weight markers. The arrows indicate the bands corresponding to pregrowth hormone (pGH) and ,,Seprolactin (pPL). Fig. 2 (right). Analysis of cDNA synthesized from mRNA extracted from the growth hormone-producing pituitary tumors, The polyadenylated RNA from tumors two, four, and five were pooled (135 ,ug) and used as a template for synthesis of 32P-labeled double-, X*anded cDNA as described (3) . Samples of this cDNA were cleaved with various restriction endonucleases before and after SI nuclease diges4k. The figure shows an autoradiogram of the resulting DNA fragments after electrophoresis on a 4. .wch end of the cDNA, and cohesive eds were generated by digestion with 6/GCC/ala 9/GAC/asp 8/GGC/gly times the codons are used in the region of hGH mRNA coding for £/GUA/va 1 1/GCA/a1 a 6/GAA/g 1 u a /GGA/g ly prehormone; OC, OP, and AM designate the stop codons ochre, opd 4/GUG/val O/GCG/ala 9/GAG/glu 3/GGG/gly and amber, respectively. Fig. 5 . Postulated nucleotidesequen- .
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to those from the 550 bp hGH cDNA clone (data not shown) and to the digested uncloned cDNA (Fig. 2) Maxam and Gilbert (11) and the chain-termination technique of Sanger, Nicklen, and Coulson (12) . The hGH mRNA sequence and the corresponding amino acid sequence of human pregrowth hormone can be derived from the DNA sequence (Fig. 3) . The amino acid sequence determined from the DNA sequence is consistent with the known amino acid sequence of hGH (13) with the following exceptions: the DNA sequence predicts glutamine, asparagine, glutamine, glutamic acid, glutamine, aspartic acid, asparagine, and glutamine at amino acid positions 29, 47, 49, 74, 91, 107, 109, and 122, respectively, while the protein sequence indicates glutamic acid, aspartic acid, glutamic acid, glutamine, glutamic acid, asparagine, aspartic acid, and glutamic acid. It is likely that the DNA sequence is correct in this regard since it is sometimes difficult in protein sequence analysis to differentiate aspartic acid from asparagine and glutamic acid from glutamine. The amino acid sequence of the signal peptide portion of human pregrowth hormone had not been previously determined and is deduced from the mRNA sequence. If translation begins with the methionine codon "in phase," 26 codons proximal to the first amino acid of growth hormone (Fig. 3) , then the primary translation product of hGH mRNA would be a protein of 24,851 daltons, a value in agreement with the cell-free translation data shown in Fig. 1 .
A comparison of the amino acid and nucleic acid sequence homologies between rat growth hormone, hGH, and hCS and their respective mRNA's is shown in Table 1 . In the coding regions, there is higher homology between the nucleic acid sequences than between the amino acid sequences. This difference is consistent with the already mentioned view that the genes of these related hormones evolved from a common evolutionary precursor gene, and is further supported by the marked homology in the 5'-noncoding portions of the mRNA's for rat and human growth hormone. (Data for the 5'-noncoding region of hCS are not yet available.) Human growth hormone has more homology with hCS than with rat growth hormone, 10 AUGUST 1979 Figure 4 shows the codons used for hGH mRNA. As is the case with rat growth hormone (3) and hCS (6) mRNA's, there is a nonrandom selection of codons. This appears to be mostly due to the preference for G (guanine) or C (cytosine) over A (adenine) or U (uracil) for the third position of the triplet codon. This is also the case with most (3, 14) but not all (14) (7) . We hoped that by placing the hGH gene sequence under control of the trp operon, not only would it be expressed, but a higher level of hGH production could be obtained than was previously achieved with rat growth hormone gene sequences under control of the 8-lactamase gene (15) .
The hGH sequences from chGH800 were inserted at the Hind III site of the trpD gene sequence as described in the legend to Fig. 5 . In order to insert the hGH codons in phase with those of the trpD sequence, the Hind III site in the trpD gene was manipulated in such a way as to shift the reading frame of any DNA inserted through the Hind III site of the plasmid by one base. To do this, ptrpED5-1 was cleaved with Hind III, the protruding 5'-ends "filled in" with the use of DNA polymerase I (Klenow fragment) and synthetic DNA decamers containing the Hind III site ligated to the blunt-ended material. This DNA was then digested with Hind III to produce new cohesive Hind III ends, and plasmid molecules were recircularized with the use of DNA ligase after the residual Hind III linker molecules were removed on a Sephadex (G-200) column. This material was used to transform E. coli and, after selection for ampicillin-resistant colonies, the plasmid DNA was isolated from one of the transformants. The DNA sequence at the Hind III site of the newly constructed plasmid (designated ptrpED50) was determined and showed that the enzymatic reactions had altered the reading frame as predicted. In this way, when chGH800/pBR322 was cleaved with Hind III and the hGH sequences ligated to the Hind III site of the newly constructed plasmid, the codons of hGH would be in phase with those of the trpD gene, provided that the hGH gene sequences were inserted in the proper orientation. This was achieved by obtaining several clones, isolating plasmid DNA, and determining the orientation of the cloned segment by restriction endonuclease analysis (Fig. 5, legend) .
As is indicated in Fig. 5 , the construction of the hGH "expression" plasmid was such that the anticipated product would be a fusion protein containing the NH2-terminal region of the trpD protein, amino acids coded by the 5'-untranslated portion of hGH mRNA, the 26 amino acids of the signal peptide, and all of the amino acids of hGH.
Synthesis of growth hormone in bacteria. To determine whether the newly constructed gene can direct the synthesis of large amounts of a new fused polypeptide, and whether its expression is regulated by the trp promoter, cells containing the expression plasmid were derepressed for trp transcription, and proteins were labeled for 5 minutes with 14C-labeled amino acids. Figure 6 shows an autoradiogram of sodium dodecyl sulfate-polyacrylamide gel of such proteins labeled at various times from 0 to 4 hours after induction of the trp operon. Two proteins (53,000 and 32,000 daltons) seem to be specifically derepressed by the inducer. The higher molecular weight protein is the trpE gene product (7) . The 32,000-dalton protein has approximately the anticipated size for the trpD-hGH fusion protein (34,000 daltons). It is immunoprecipitated by antiserum to hGH (Fig. 6, lane a) but not by the control antiserum (Fig. 6, lane b) , and precipitati6n can be blocked by a large excess of hGH (Fig. 6, lanes c to h) . Some of the trpE protein is immunoprecipitated by antiserum to hGH, but the amount is less when an excess of competitor hGH is added or control antiserum is used. This the natural hGH gene sequence can be expressed at a high level in bacteria. The trpE and trpD protein molecules ordinarily accumulate at a similar rate (molar ratio 1:1) when the trp operon is induced (7) . However, the molar ratio of trpE to trpD-hGH is about 6:1, indicating that synthesis of trpD-hGH is only 17 percent of the expected level. The reduced level of synthesis is not due to instability of the fused polypeptide since a "'pulse-chase" experiment has shown that no significant degradation of the fused polypeptide occurs during the 60-minute period after incorporation of the label (data not shown). There is some evidence that the chick ovalbumin protein is also synthesized in E. coli at lower levels than expected (18) .
Hypopituitary dwarfism is a fairly common disease treatable only by replacement with hGH (19) . Growth hormone may also be useful in the treatment of other disorders. However, the potential uses of this hormone have not been adequately investigated because its only source is pituitaries from human cadavers. In order to have an adequate supply of this hormone, it is necessary to find alternative means of producing it; the synthesis of hGH in bacteria may provide such a means. cus on polymerization in systems of liquid crystalline character. The contributions so far have mainly been in the area of thermotropic liquid crystals (6) ; the equilibrium problems being more complex in lyotropic structures, which by definition are multicomponent systems.
Early attempts to polymerize in lyotropic liquid crystals (7-10) have recently (11, 12) been criticized as achieving retention of the long-range order by freezing the structure with cross-coupling agents rather than forming an equilibrium liquid crystal. The conditions for polymerization with retained liquid crystalline structure have been stated (11) by comparison with homotropic polymerization in crystalline structures (12) (13) (14) (15) . For a liquid crystalline structure the translational entropy component in the expression for the total free energy should also be included. Its magnitude is diflicult to estimate; for microemulsions (16) the contribution of the entropic free energy is similar in magnitude to the contributions of other components of the free energy.
The fact that polymerization with retention of the liquid crystalline structure may be a rare phenomenon in lyotropic liquid crystals (11) encouraged us to choose an alternative route: to observe structural changes during polymerization in a lyotropic liquid crystalline matrix. We are now able to report a change from one liquid crystalline structure to another during polymerization of the amphiphilic component. To our knowledge, this is the first report of such a change.
It is essential to realize that the structure obtained represents the stable conformation of the system; there is no "freezing in" of a structure-it forms spontaneously from an isotropic melt.
The components of the liquid crystal were distilled water (with O.05M ammonium persulfate as an initiator) and sodium undecenoate. They formed a liquid crystal in the concentration range 47 to 59 percent sodium undecenoate (by Abstract. Optical patterns in polarized light and x-ray reflections in the low-angle region were used to detect a shift from one liquid crystalline structure to another during polymerization. The polymerization took place in a lyotropic liquid crystal of water and sodium undecenoate, with a structure consisting of cylinders in a twodimensional hexagonal close packing. After polymerization, a lamellar liquid crystalline structure was obtained. 10 AUGUST 1979
